# US 2026/0295057 A1 · Three-arm polyethylene glycol derivative containing amino acid residues

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0295057 A1
- Document ID: US20260295057A1
- Status: Published application
- Kind: A1
- Application number: 18/874,420
- Filed: 2023-07-21
- Published: 2026-10-01
- Earliest claimed: 2022-07-28
- Assignees: Xiamen Sinopeg Biotech Co., Ltd.
- Applicants: Xiamen Sinopeg Biotech Co., Ltd.
- Inventors: Wengui WENG; Chao LIU; Ailan WANG; Dandan CHEN; Sheng LIN; Qi ZHU
- Web page: https://patentgrep.com/patent/US20260295057A1

## CPC

- A61K 47/64: Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers A61K47/65)
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A three-arm polyethylene glycol derivative containing amino acid moieties (Formula 1), wherein ni is the degree of polymerization and is an integer from 30 to 1000; R2 is C1-6 alkyl; L1A, L1B, and L2 are divalent linking groups; Lys is a lysine residue; AA1 and AA2 are residues of amino acids or amino acid derivatives; p is an integer from 1 to 5, with —(AA1)p—representing a divalent residue formed by p AA1 units; q is 0 or 1, indicating the absence or presence of AA2; L3 is a linking bond or divalent linking group; R01 is H or a functional group capable of reacting with bio-related substances, optionally protected; and m is 1 or 2. This derivative is degradable within cells, prevents vacuole formation at higher molecular weights, and can modify drugs or bio-related substances, offering high biocompatibility, low toxicity, and excellent drug activity retention.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A three-arm polyethylene glycol derivative having the structure represented by general formula (1):
or a pharmaceutically acceptable salt, tautomer, stereoisomer or solvate thereof;
wherein,
n1, n2, and n3 are the degrees of polymerization of the polyethylene glycol chains, each being independently an integer in the range of 30 to 1000;
R2 is, at each occurrence, independently a C1-6 alkyl group;
L1A, L1B, and L2 are each independently a divalent linking group;
Lys is a residue of lysine;
AA1 and AA2 are each independently a residue of amino acid or amino acid derivative; p is an integer in the range of 1 to 5, and —(AA1)p— represents a divalent residue formed by the combination of p units of AA1; q is 0 or 1, indicating the absence of AA2 or the presence of one AA2;
L3 is a linking bond or a divalent linking group;
R01 is H, a functional group capable of reacting with bio-related substances, or a protected form of the functional group; m is 1 or 2; when m is 2, the structures of two L3 are identical or different, and the structures of two R01 are identical or different;
the three-arm polyethylene glycol derivative is monodisperse or polydisperse.

### Claim 16 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein the number average molecular weight of each PEG chain is 1000, 1500, 2000, 2500, 3000, 3350, 3500, 4000, 5000, 5500, 6000, 6500, 7000, 7500, 8000, 8500, 9000, 9500, 10000, 11000, 12000, 13000, 14000, 15000, 16000, 17000, 18000, 19000, or 20000 Da.

### Claim 17 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein n1, n2, and n3 are each independently an integer in the range of 30 to 500.

### Claim 18 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein R01 is selected from the group consisting of an epoxy group, a hydroxyl group, a thiol group, a carboxyl group, an amino group, an aldehyde group, an active ester group, an active carbonate group, a carbamate group, an isocyanate group, an isothiocyanate group, a succinimide group, a maleimide group, an alkenyl group, an alkynyl group, an enoate group, an azido group, a cyano group, a dithiopyridyl group, an α-haloacetyl alkynyl group, a folic acid group, a rhodamine group, a biotin group, a monosaccharide group, a polysaccharide group, and protected forms thereof.

### Claim 19 (depends on 18)

The three-arm polyethylene glycol derivative according to claim 18, wherein R01 is selected from the group consisting of the following structures:

### Claim 20 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein L2 is selected from the group consisting of —(CH2)tp—, —(CH2)tqC(═O)—, —C(═O)(CH2)tqC(═O)—, —(CH2)tqNHC(═O)(CH2)tqC(═O)—, and —(CH2)tqC(═O)NH(CH2)tqC(═O)—; wherein, tp is an integer in the range of 1 to 4; tq is, at each occurrence, independently an integer in the range of 0 to 4; the right end of the linking group is connected to the residue of lysine of general formula (1).

### Claim 21 (depends on 20)

The three-arm polyethylene glycol derivative according to claim 20, wherein L2 is selected from the group consisting of —C(═O)—, —CH2C(═O)—, —CH2CH2C(═O)—, —CH2CH2CH2C(═O)—, —C(═O)CH2CH2C(═O)—, —C(═O)CH2CH2CH2C(═O)—, —CH2CH2NHC(═O)CH2CH2C(═O)—, —CH2CH2CH2NHC(═O)CH2CH2C(═O)—, —CH2CH2NHC(═O)CH2CH2CH2C(═O)—, —CH2CH2CH2NHC(═O)CH2CH2CH2C(═O)—, —CH2C(═O)NHCH2C(═O)—, —CH2CH2C(═O)NHCH2C(═O)—, and —CH2CH2CH2C(═O)NHCH2C(═O)—; the right end of the linking group is connected to the residue of lysine of general formula (1).

### Claim 22 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein L3 is selected from the group consisting of a linking bond, an alkylene group, —C(═O)—, —OC(═O)—, —C(═O)O—, —OC(═O)O—, —O—, —S—, —S—S—, —C(═O)S—, —SC(═O)—, —NRc—, —NRcC(═O)—, —C(═O)NRc—, —NRcC(═O)NRc—, —OC(═O)NRc—, —NRcC(═O)O—, —SC(═O)NRc—, —NRcC(═O)S—, and combinations thereof;
Rc is selected from the group consisting of H, a C1-6 alkyl group, a carbocyclic group, and a heterocyclic group;
the alkylene group is —(CRaRb)t—; wherein, t is, at each occurrence, independently an integer in the range of 1 to 12; t instances of Ra and t instances of Rb are identical, or a combination of two or more different structures; Ra and Rb are, at each occurrence, independently —CH3 or —H.

### Claim 23 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein p instances of AA1 and q instances of AA2 are each independently selected from the group consisting of the residues of glycine, alanine, β-alanine, valine, leucine, isoleucine, phenylalanine, tryptophan, tyrosine, aspartic acid, histidine, asparagine, glutamic acid, lysine, glutamine, methionine, arginine, serine, threonine, cysteine, ornithine, citrulline, and derivatives thereof;
when p=1, —AA1— is a residue of glycine;
when p≥2, —(AA1)p— is a residue of oligopeptide or oligopeptide derivative; the oligopeptide is a dipeptide, tripeptide, tetrapeptide, or pentapeptide, and is selected from the group consisting of glycine-phenylalanine, histidine-β-alanine, glycine-glycine, lysine-glycine, lysine-glutamic acid, glycine-glycine-glycine, glycine-glycine-phenylalanine, glycine-phenylalanine-glycine, glycine-lysine-glycine, glycine-histidine-lysine, glycine-cysteine-glutamic acid, glycine-leucine-glycine, valine-citrulline-glycine, valine-alanine-glycine, arginine-glycine-aspartic acid, glycine-histidine-proline, glycine-leucine-phenylalanine-glycine, glycine-glycine-phenylalanine-glycine, glycine-lysine-glycine-lysine, glycine-phenylalanine-glutamic acid-phenylalanine-glycine, and arginine-lysine-aspartic acid-valine-tyrosine;
when q is 1, AA2 is a residue of glutamic acid or aspartic acid.

### Claim 24 (depends on 23)

The three-arm polyethylene glycol derivative according to claim 23, wherein p is 1 and AA1 is a residue of glycine; the structure of the three-arm polyethylene glycol derivative is represented by general formula (2):
wherein,
L1A and L1B are each independently a C1-6 alkylene group or —(CH2)1-6C(═O)—, wherein the left end of each linking group is connected to a PEG chain; L1A and L1B conform to any one of the following cases:
Case (1): L1A and L1B are each independently —CH2CH2— or —CH2—;
Case (2): one of L1A and L1B is —CH2CH2— or —CH2—, and the other is —CH2C(═O)— or —CH2CH2C(═O)—.

### Claim 25 (depends on 24)

The three-arm polyethylene glycol derivative according to claim 24, wherein q is 0 and AA2 is absent; the structure of the three-arm polyethylene glycol derivative is represented by general formula (3):
wherein, L3 is selected from the group consisting of a linking bond, —O—, —O(CH2)tpOC(═O)O—, —NH(CH2)tp—, —NH(CH2)tpC(═O)NH(CH2)tp —, and —NH(CH2)tpNHC(═O)(CH2)tp—, and the right end of L3 is connected to R01; tp is an integer in the range of 1 to 4;
R01 is selected from the group consisting of —OH, —CHO, —COGH, —NH2,

### Claim 26 (depends on 25)

The three-arm polyethylene glycol derivative according to claim 25, wherein the structure of the three-arm polyethylene glycol derivative is selected from the group consisting of the following structural formulas:

### Claim 27 (depends on 24)

The three-arm polyethylene glycol derivative according to claim 24, wherein q is 1 and one AA2 is present; the structure of the three-arm polyethylene glycol derivative is represented by general formula (4):
wherein,
R01 is —OH or —CHO;
L3 is a linking bond or —NH(CH2)tp—, and the right end of L3 is connected to R01; tp is an integer in the range of 1 to 4;
AA2 is a trivalent residue of glutamic acid or aspartic acid.

### Claim 28 (depends on 27)

The three-arm polyethylene glycol derivative according to claim 27, wherein the structure of the three-arm polyethylene glycol derivative is selected from the group consisting of the following structural formulas:

### Claim 29 (depends on 15)

The three-arm polyethylene glycol derivative according to claim 15, wherein the structure is selected from the group consisting of the following structural formulas:

### Claim 30 (depends on 23)

The three-arm polyethylene glycol derivative according to claim 23, wherein p is 2 and —(AA1)2— is a residue of phenylalanine-glycine dipeptide; the structure of the three-arm polyethylene glycol derivative is represented by general formula (2-B):
wherein,
L1A and L1B are each independently a C1-6 alkylene group or —(CH2)1-6C(═O)—, wherein the left end of each linking group is connected to a PEG chain; L1A and L1B conform to any one of the following cases:
Case (1): L1A and LIB are each independently —CH2CH2— or —CH2—;
Case (2): one of L1A and LIB is —CH2CH2— or —CH2—, and the other is —CH2C(═O)— or —CH2CH2C(═O)—.

### Claim 31 (depends on 15)

A bio-related substance modified with a three-arm polyethylene glycol derivative, having the structure represented by general formula (5):
wherein, P is a residue of the three-arm polyethylene glycol derivative of claim 15, D is a residue of bio-related substance, and L is a divalent linking group formed by the reacting the functional group of the three-arm polyethylene glycol derivative with the bio-related substance;
the bio-related substance is selected from the group consisting of small molecule drugs, nucleic acids, steroids, phospholipids, and glycolipids; the small molecule drugs are selected from the group consisting of flavonoids, terpenoids, carotenoids, saponins, steroids, sterols, quinones, anthraquinones, fluoroquinones, coumarins, alkaloids, porphyrins, polyphenols, macrolides, monobactams, phenylpropanoid phenols, anthracyclines, and aminoglycosides.

### Claim 32 (depends on 31)

The bio-related substance modified with a three-arm polyethylene glycol derivative according to claim 31, wherein the bio-related substance is a genetically engineered drug, selected from the group consisting of antibodies, antibody fragments, interleukins, lysozymes, interferons, growth hormones, erythropoietins, and granulocyte colony-stimulating factors.

### Claim 33 (depends on 32)

The bio-related substance modified with a three-arm polyethylene glycol derivative according to claim 32, wherein the interferons area-, β- or γ-interferons.
